Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03759366 |
|---|---|
| Brief Title: | A Phase 3 Open-Label Study of Eculizumab in Pediatric Participants With Refractory Generalized Myasthenia Gravis (gMG) |
| First Submitted : | November 26, 2018 |
| First Submitted that Met QC Criteria : | November 28, 2018 |
| First Posted : | November 30, 2018 |
| Results First Submitted : | August 1, 2022 |
| Results First Submitted that Met QC Criteria : | August 1, 2022 |
| Results First Posted : | August 25, 2022 |
| Last Update Submitted that Met QC Criteria : | November 28, 2023 |
| Last Update Posted : | December 18, 2023 |